Catalyst Pharmaceuticals (CPRX) EBITDA Margin (2018 - 2026)
Catalyst Pharmaceuticals (CPRX) recorded EBITDA Margin of 55.56% in Q1 2026, up 4.07 percentage points from 51.50% a year earlier and up 8.79 percentage points from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) EBITDA Margin (2018 - 2026) Analysis & Trends
On a TTM basis, Catalyst Pharmaceuticals' EBITDA Margin came in at 51.23% as of Mar 31, 2026, up 0.89 percentage points year-over-year; for FY2025, it was 50.20%, up 2.83 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +15.43 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 47.36% in FY2024 (+17.30 pp), 30.06% in FY2023 (-18.06 pp), 48.12% in FY2022 (+10.79 pp) and 37.33% in FY2021 (+2.57 pp).
- The Q1 2026 figure is the highest quarterly EBITDA Margin in data going back to Q4 2018.
- On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of +11.79 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 74.77 percentage points in Q3 2024, against a drop of 71.78 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 46.77% (Q4 2025), 51.00% (Q3 2025) and 51.69% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 55.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 55.56% |
| Dec 31, 2025 | 46.77% |
| Sep 30, 2025 | 51.00% |
| Jun 30, 2025 | 51.69% |
| Mar 31, 2025 | 51.50% |
| Dec 31, 2024 | 50.98% |
| Sep 30, 2024 | 46.90% |
| Jun 30, 2024 | 51.90% |
| Mar 31, 2024 | 37.11% |
| Dec 31, 2023 | 45.98% |
| Sep 30, 2023 | -27.87% |
| Jun 30, 2023 | 55.50% |
| Mar 31, 2023 | 49.44% |
| Dec 31, 2022 | 51.71% |
| Sep 30, 2022 | 43.91% |
| Jun 30, 2022 | 53.86% |
| Mar 31, 2022 | 40.38% |
| Dec 31, 2021 | 33.35% |
| Sep 30, 2021 | 39.04% |
| Jun 30, 2021 | 43.64% |
API Access
Catalyst Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();